Document Detail

A new role for cyclic phosphatidic acid as a PPARgamma antagonist.
MedLine Citation:
PMID:  20816085     Owner:  NLM     Status:  PubMed-not-MEDLINE    
A recent study in Molecular Cell (Tsukahara et al., 2010) identifies cyclic phosphatidic acid (CPA) as a naturally occurring PPARgamma antagonist that can be generated from lysophospholipids by signal-dependent activation of phospholipase D2. This endogenous CPA regulates PPARgamma functions required for adipogenesis, glucose homeostasis, and vascular wall biology.
Yumiko Oishi-Tanaka; Christopher K Glass
Related Documents :
3634775 - Studies on the antibacterial activity of dodecylglycerol. its limited metabolism and in...
19369695 - Enzymatic measurement of phosphatidic acid in cultured cells.
1686905 - Lysophosphatidic acids induce contraction of rat isolated colon by two different mechan...
184825 - Selective utilization of endogenous unsaturated phosphatidylcholines and diacylglycerol...
11334555 - Brain and hippocampus fatty acid composition in phospholipid classes of aged-relative c...
7216475 - Effect of bile acid derivatives on taurine biosynthesis and extracellular slime product...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cell metabolism     Volume:  12     ISSN:  1932-7420     ISO Abbreviation:  Cell Metab.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-06     Completed Date:  2010-11-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101233170     Medline TA:  Cell Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  207-8     Citation Subset:  -    
Copyright Information:
Copyright © 2010 Elsevier Inc. All rights reserved.
Department of Cellular and Molecular Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0651, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Separating the good and evil of cardiac growth by CIB1 and calcineurin.
Next Document:  The long and short of fertility and longevity.